background: organisms producing ctx-m-β-lactamase are emerging around the world as a source of resistance to oxyiminocephalosporins such as cefotaxime. however, the laboratory detection of these strains is not well defined. the aim of this study was to determine the presence and prevalence of known ctx-m-β-lactamases genes in clinical isolates of  escherichia coli from hospitals of tehran. meth...

background and objectives: klebsiella pneumoniae is an opportunistic pathogen responsible for up to 10% of nosocomial infections. the emergence and spread of multidrug resistant k. pneumoniae , mostly due to the production of extended-spec- trum β-lactamases (esbl) and carbapenemases, is often responsible for antibiotic treatment failure of these infections. we compared the antibiotic resistanc...

The presence of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli was investigated in input (manure from livestock husbandry) and output samples of six German biogas plants in 2012 (one sampling per biogas plant) and two German biogas plants investigated in an annual cycle four times in 2013/2014. ESBL-producing Escherichia coli were cultured by direct plating on CHROMagar ESBL...

Bacteria infections associated with multidrug resistance have been implicated in the high mortality and morbidity reported among cancer patients. In recent years gram negative organisms isolates from patients with neoplasia have been found to produce beta-lactamases (β-lactamase) and this is of interest in developing countries where it is unreported or underreported. This study determined beta-...

b ackground: the prevalence of antibiotic resistance among extended spectrum  β-lactamase  (esbl)  producing  escherichia  coli  and  klebsiella  pneumoniae  has been increased  markedly  in recent  years. the present study was done to know the prevalence  of esbl production among isolates of e. coli and k. pneumoniae and to study the susceptibility pattern of isolates against different antibio...

BACKGROUND AND PURPOSE Infections due to extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae (ESBL-EC and ESBL-KP) have become an important clinical problem. Local knowledge of antimicrobial susceptibilities of these organisms is important for implementation of effective hospital anti-infective policies. METHODS We analyzed the activities of various an...

We determined the presence of extended-spectrum-β-lactamase (ESBL)-producing Escherichia coli among 3,344 study participants from the German community. Intestinal colonization was detected in 211 persons (6.3%), without significant differences among the different age groups. The majority (95.2%) of isolates harbored CTX-M-type ESBL, with CTX-M-15 (46%) and CTX-M-1 (24.2%) as the most common typ...

An infected cephalhematoma is a rare condition in neonates. We report a case of an 18-day-old neonate who was diagnosed with an infected cephalhematoma caused by an extended spectrum beta-lactamase (ESBL)-producing Escherichia coli complicated with septicemia, meningitis, and skull osteomyelitis. He was successfully treated with meropenem and surgical incision and drainage. ESBL-producing E. co...

We report on an 8-year-old patient with septicaemia unresponsive to therapy for five weeks. Undetected, extended-spectrum β-lactamase (ESBL) production by the infecting Klebsiella strain was regarded as responsible for treatment failure. Intravenously administered imipenem during the sixth week led to sustained resolution of fever. Resource-limited hospitals can incur prohibitive costs from ESB...

Ertapenem (MK-0826; L-749,345), a new carbapenem with a long serum half-life, was tested, in vitro, against -lactamase-producing bacteria. The new compound had a MIC at which 90% of the isolates were inhibited of 0.06 g/ml for extended-spectrum -lactamase (ESBL)-producing klebsiellas, compared with 0.5 g/ml for imipenem, 16 g/ml for cefepime, and >128 g/ml for ceftazidime and piperacillin-tazob...